Bioethics, Ltd. (BOTH)

Bioethics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0	0	0	0
Cash & Short-Term Investments	0.01	0	0	0	0
Cash Growth	10526.09%	-53.22%	-59.81%	10.04%	-92.39%
Total Current Assets	0.01	0	0	0	0
Property, Plant & Equipment	-	-	-	-	0
Total Assets	0.01	0	0	0	0
Accounts Payable	0.19	0.12	0.1	0.08	0.05
Accrued Expenses	0.17	0.21	0.16	0.11	0.06
Short-Term Debt	0.59	0.44	0.42	0.4	0.37
Total Current Liabilities	0.95	0.78	0.68	0.59	0.48
Total Liabilities	0.95	0.78	0.68	0.59	0.48
Common Stock	0	0	0	0	0
Additional Paid-In Capital	0.52	0.5	0.5	0.5	0.5
Retained Earnings	-1.45	-1.28	-1.18	-1.09	-0.98
Shareholders' Equity	-0.93	-0.78	-0.68	-0.59	-0.48
Total Liabilities & Equity	0.01	0	0	0	0
Total Debt	0.59	0.44	0.42	0.4	0.37
Net Cash (Debt)	-0.57	-0.44	-0.42	-0.39	-0.36
Net Cash Per Share	-0.38	-0.39	-0.36	-0.35	-0.32
Filing Date Shares Outstanding	3.6	1.14	1.14	1.14	1.14
Total Common Shares Outstanding	3.34	1.14	1.14	1.14	1.14
Working Capital	-0.93	-0.78	-0.68	-0.59	-0.48
Book Value Per Share	-0.28	-0.68	-0.60	-0.52	-0.42
Tangible Book Value	-0.93	-0.78	-0.68	-0.59	-0.48
Tangible Book Value Per Share	-0.28	-0.68	-0.60	-0.52	-0.42
Machinery	-	-	-	-	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.